PMC5943875_01
Abdominal computed tomography showing multiple lymphadenectasis at abdominal cavity, retroperitoneum, and bilateral inguens before chemotherapy with chidamide.
medi-97-e9611-g001.jpg
PMC5943875_01_medi-97-e9611-g001.jpg
F1
CT showed multiple lymphadenectasis at abdominal cavity, retroperitoneum, and bilateral inguens (Fig. 1). Chest CT displayed multiple lymphadenectasis at mediastinum and bilateral axillas (Fig. 2).
Chest computed tomography showing multiple lymphadenectasis at mediastinum and bilateral axillas before chemotherapy with chidamide.
medi-97-e9611-g002.jpg
PMC5943875_01_medi-97-e9611-g002.jpg
F2
CT showed multiple lymphadenectasis at abdominal cavity, retroperitoneum, and bilateral inguens (Fig. 1). Chest CT displayed multiple lymphadenectasis at mediastinum and bilateral axillas (Fig. 2).
Rashes on the patient with angioimmunoblastic T-cell lymphoma. (A) Rashes of the patient after 9 courses of chemotherapy and before chemotherapy with chidamide. (B) Subsided rashes one month after the patient begins oral intake of chidamide.
medi-97-e9611-g003.jpg
PMC5943875_01_medi-97-e9611-g003.jpg
F3
Later, the patient developed systemic rashes at face, trunk, and limbs, with no obvious causes (Fig. 3). The condition of the patient was stable, and rashes disappeared, but pigmentation of skin remained (Fig. 3B).
Chest computed tomography showing shrunken lymph nodes 6 months after the patient began oral intake of chidamide.
medi-97-e9611-g004.jpg
PMC5943875_01_medi-97-e9611-g004.jpg
F4
August 31st, chest CT showed multiple small lymph nodes at mediastinum and axillas (Fig. 4). Abdominal CT showed no lymphadenectasis (Fig. 5).
Abdominal computed tomography showing shrunken lymph nodes 6 months after the patient began oral intake of chidamide.
medi-97-e9611-g005.jpg
PMC5943875_01_medi-97-e9611-g005.jpg
F5
August 31st, chest CT showed multiple small lymph nodes at mediastinum and axillas (Fig. 4). Abdominal CT showed no lymphadenectasis (Fig. 5).